Bernd Eberle

Title: Bernd Eberle: Innovator in Personalized Peritoneal Dialysis Treatment

Introduction

Bernd Eberle is a notable inventor based in Herschweiler-Pettersheim, Germany. He has made significant contributions to the field of medical technology, particularly in the area of personalized peritoneal dialysis (PD) treatment. His innovative approach utilizes design of experiment techniques to optimize dialysis processes for patients.

Latest Patents

Eberle holds a patent for a technology titled "Personalized peritoneal dialysis treatment using design of experiment techniques." This patent describes systems and processes that optimize PD by estimating and predicting the value of PD dose variables based on patient characteristics and PD prescription information. The technology includes a UFV determination process that predicts the ultrafiltration volume (UFV) for patients. Additionally, it may involve training a computational model to generate predicted UFV outputs based on various inputs, including patient characteristics and historical data. The system also incorporates a feedback control process that continuously measures intraperitoneal pressure and hydration status to maintain the patient's hydration within target levels.

Career Highlights

Throughout his career, Bernd Eberle has worked with prominent companies in the healthcare sector. He has been associated with Fresenius Medical Care Holdings, Inc. and Fresenius Medical Care Deutschland GmbH. His experience in these organizations has contributed to his expertise in medical technologies and patient care solutions.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Bernd Eberle's work in personalized peritoneal dialysis treatment exemplifies the impact of innovative thinking in healthcare. His patent and career achievements highlight his commitment to improving patient outcomes through advanced medical technologies.